91 related articles for article (PubMed ID: 14566024)
1. Cytokeratin immunoreactivity in lobular intraepithelial neoplasia.
Bratthauer GL; Miettinen M; Tavassoli FA
J Histochem Cytochem; 2003 Nov; 51(11):1527-31. PubMed ID: 14566024
[TBL] [Abstract][Full Text] [Related]
2. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.
Bratthauer GL; Moinfar F; Stamatakos MD; Mezzetti TP; Shekitka KM; Man YG; Tavassoli FA
Hum Pathol; 2002 Jun; 33(6):620-7. PubMed ID: 12152161
[TBL] [Abstract][Full Text] [Related]
3. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
[TBL] [Abstract][Full Text] [Related]
4. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
[TBL] [Abstract][Full Text] [Related]
5. DCIS and LCIS are confusing and outdated terms. They should be abandoned in favor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN).
Galimberti V; Monti S; Mastropasqua MG
Breast; 2013 Aug; 22(4):431-5. PubMed ID: 23643807
[TBL] [Abstract][Full Text] [Related]
6. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations as detected by array comparative genomic hybridization in early low-grade intraepithelial neoplasias of the breast.
Stacher E; Boldt V; Leibl S; Halbwedl I; Popper HH; Ullmann R; Tavassoli FA; Moinfar F
Histopathology; 2011 Sep; 59(3):549-55. PubMed ID: 21906127
[TBL] [Abstract][Full Text] [Related]
8. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer.
Varma M; Morgan M; Amin MB; Wozniak S; Jasani B
Histopathology; 2003 Feb; 42(2):167-72. PubMed ID: 12558749
[TBL] [Abstract][Full Text] [Related]
9. A keratin epitope that is exposed in a subpopulation of preneoplastic and neoplastic mouse mammary epithelial cells but not in normal cells.
Asch BB; Asch HL
Cancer Res; 1986 Mar; 46(3):1255-62. PubMed ID: 2417702
[TBL] [Abstract][Full Text] [Related]
10. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
Gottlieb C; Raju U; Greenwald KA
Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
[TBL] [Abstract][Full Text] [Related]
11. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast.
Wetzels RH; Holland R; van Haelst UJ; Lane EB; Leigh IM; Ramaekers FC
Am J Pathol; 1989 Mar; 134(3):571-9. PubMed ID: 2466404
[TBL] [Abstract][Full Text] [Related]
12. Reproducible and highly sensitive detection of the broad spectrum epithelial marker keratin 19 in routine cancer diagnosis.
Kwaspen FH; Smedts FM; Broos A; Bulten H; Debie WM; Ramaekers FC
Histopathology; 1997 Dec; 31(6):503-16. PubMed ID: 9447381
[TBL] [Abstract][Full Text] [Related]
13. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers.
Tang P; Wang X; Schiffhauer L; Wang J; Bourne P; Yang Q; Quinn A; Hajdu SI
Ann Clin Lab Sci; 2006; 36(1):16-22. PubMed ID: 16501232
[TBL] [Abstract][Full Text] [Related]
14. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
15. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin immunoreactivity in mouse tissues: study of different antibodies with a new detection system.
Martín CA; Salomoni PD; Badrán AF
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):70-3. PubMed ID: 11277418
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues.
van Niekerk CC; Jap PH; Ramaekers FC; van de Molengraft F; Poels LG
J Pathol; 1991 Oct; 165(2):145-52. PubMed ID: 1720817
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial 65,000 MW heat-shock protein shares a carboxy-terminal epitope with human epidermal cytokeratin 1/2.
Rambukkana A; Das PK; Krieg S; Young S; Le Poole IC; Bos JD
Immunology; 1992 Oct; 77(2):267-76. PubMed ID: 1385316
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
Wada T; Yasutomi M; Yamada K; Hashimura K; Kunikata M; Tanaka T; Huang JW; Mori M
Anticancer Res; 1991; 11(6):1983-93. PubMed ID: 1723260
[TBL] [Abstract][Full Text] [Related]
20. Double immunohistochemical labeling technique applied to different types of cytokeratins in epithelial proliferations of the breast.
Denoux Y; Lebeau CH; Michels JJ; Chasle J
Biotech Histochem; 2003 Feb; 78(1):23-6. PubMed ID: 12713138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
